Shared decision-making (also called individual-based decision-making) for COVID-19 vaccination requires that an individual consult a health care provider, such as a doctor or pharmacist, about the risks and benefits before receiving the vaccine.
October 06, 2025
high
process
Definition of the consultation requirement described for COVID-19 vaccination decisions.
The Vaccines for Children Program provides vaccines free to about 40% of all U.S. children.
October 06, 2025
high
statistic
Baseline statistic about the scope of the Vaccines for Children Program.
Dorit Reiss, a vaccine policy researcher at the University of California, San Francisco, stated that shared clinical decision-making signals that a vaccine is not routinely recommended and tends to decrease vaccine uptake.
October 06, 2025
medium
claim
Expert statement about the expected effect of shared clinical decision-making on vaccine uptake.
Merck stated that there were no approved U.S. monovalent single-antigen vaccines for measles, mumps, or rubella as of 2025-10-06.
October 06, 2025
high
regulatory
Manufacturer statement about available vaccine approvals in the United States.
Merck stated that evidence suggests use of combination vaccines for measles, mumps, and rubella improves childhood vaccination outcomes by increasing both completion (receipt of all recommended doses) and compliance (age-appropriate administration) rates.
October 06, 2025
high
clinical_evidence
Claim about the impact of combination vaccines on vaccination completion and timeliness.
In 2022, the Centers for Disease Control and Prevention issued a blanket recommendation endorsing ongoing COVID-19 booster vaccinations.
January 01, 2022
high
policy
Description of a past CDC policy regarding COVID-19 boosters.